Rogge MC - Search Results

1

Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys.

Gobburu JV, Tenhoor C, Rogge MC, Frazier DE Jr, Thomas D, Benjamin C, Hess DM, Jusko WJ. Gobburu JV, et al. Among authors: rogge mc. J Pharmacol Exp Ther. 1998 Aug;286(2):925-30. J Pharmacol Exp Ther. 1998. PMID: 9694951

2

Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects.

Li Z, TenHoor C, Marbury T, Swan S, Ticho B, Rogge M, Nestorov I. Li Z, et al. J Clin Pharmacol. 2011 Jul;51(7):1004-14. doi: 10.1177/0091270010377633. Epub 2010 Oct 6. J Clin Pharmacol. 2011. PMID: 20926751 Clinical Trial.

3

Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers.

Meier W, Gill A, Rogge M, Dabora R, Majeau GR, Oleson FB, Jones WE, Frazier D, Miatkowski K, Hochman PS. Meier W, et al. Ther Immunol. 1995 Jun;2(3):159-71. Ther Immunol. 1995. PMID: 8885134

4

A Semi-Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy.

Biliouris K, Gaitonde P, Yin W, Norris DA, Wang Y, Henry S, Fey R, Nestorov I, Schmidt S, Rogge M, Lesko LJ, Trame MN. Biliouris K, et al. CPT Pharmacometrics Syst Pharmacol. 2018 Sep;7(9):581-592. doi: 10.1002/psp4.12323. Epub 2018 Aug 16. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 30043511 Free PMC article.

5

Effect of food and a monoglyceride emulsion formulation on danazol bioavailability.

Charman WN, Rogge MC, Boddy AW, Berger BM. Charman WN, et al. Among authors: rogge mc. J Clin Pharmacol. 1993 Apr;33(4):381-6. doi: 10.1002/j.1552-4604.1993.tb04673.x. J Clin Pharmacol. 1993. PMID: 8473554 Clinical Trial.

6

The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin.

Rogge MC, Solomon WR, Sedman AJ, Welling PG, Koup JR, Wagner JG. Rogge MC, et al. Clin Pharmacol Ther. 1989 Oct;46(4):420-8. doi: 10.1038/clpt.1989.160. Clin Pharmacol Ther. 1989. PMID: 2791445 Free article.

7

Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.

Lee H, Kimko HC, Rogge M, Wang D, Nestorov I, Peck CC. Lee H, et al. Clin Pharmacol Ther. 2003 Apr;73(4):348-65. doi: 10.1016/s0009-9236(02)17635-1. Clin Pharmacol Ther. 2003. PMID: 12709725 Clinical Trial.

8

Population pharmacokinetics of recombinant factor VIII Fc fusion protein.

Nestorov I, Neelakantan S, Ludden TM, Li S, Jiang H, Rogge M. Nestorov I, et al. Clin Pharmacol Drug Dev. 2015 May-Jun;4(3):163-74. doi: 10.1002/cpdd.167. Epub 2014 Oct 27. Clin Pharmacol Drug Dev. 2015. PMID: 27140796 Clinical Trial.

9

Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers.

Munafo A, Priestley A, Nestorov I, Visich J, Rogge M. Munafo A, et al. Eur J Clin Pharmacol. 2007 Jul;63(7):647-56. doi: 10.1007/s00228-007-0311-7. Epub 2007 May 1. Eur J Clin Pharmacol. 2007. PMID: 17473917 Clinical Trial.

10

A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.

Hu X, Miller L, Richman S, Hitchman S, Glick G, Liu S, Zhu Y, Crossman M, Nestorov I, Gronke RS, Baker DP, Rogge M, Subramanyam M, Davar G. Hu X, et al. J Clin Pharmacol. 2012 Jun;52(6):798-808. doi: 10.1177/0091270011407068. Epub 2011 Jun 16. J Clin Pharmacol. 2012. PMID: 21680782 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page